case_images: PMC5469985_01
case_images: Esophageal tumor seen during EGD.
case_images: CRIGM2017-9343896.001.jpg
case_images: PMC5469985_01_CRIGM2017-9343896.001.jpg
case_images: fig1
case_images: Due to her complaints and findings of iron deficiency, esophagogastroduodenoscopy (EGD) was done and showed a mass at the distal esophagus causing a tight stricture (Figure 1).
case_images: H&E stain of the esophageal tumor showing adenocarcinoma.
case_images: CRIGM2017-9343896.002.jpg
case_images: PMC5469985_01_CRIGM2017-9343896.002.jpg
case_images: fig2
case_images: The biopsy showed adenocarcinoma of the esophagus (Figure 2).
case_images: H&E stain from liver biopsy with morphologically similar cells to the esophagus biopsy.
case_images: CRIGM2017-9343896.003.jpg
case_images: PMC5469985_01_CRIGM2017-9343896.003.jpg
case_images: fig3
case_images: The liver lesions were biopsied and the cells were morphologically similar to the cells from the esophageal tumor (Figure 3).
case_images: H&E stain of the bladder tumor with morphologically similar cells to the esophagus biopsy.
case_images: CRIGM2017-9343896.004.jpg
case_images: PMC5469985_01_CRIGM2017-9343896.004.jpg
case_images: fig4
case_images: Pathology was compared to the previous biopsy of the liver and was thought to be morphologically similar (Figure 4).
case_images: Bladder tumor with CK20 positive stain.
case_images: CRIGM2017-9343896.005.jpg
case_images: PMC5469985_01_CRIGM2017-9343896.005.jpg
case_images: fig5
case_images: Bladder tumor with positive stain for CDX2.
case_images: CRIGM2017-9343896.006.jpg
case_images: PMC5469985_01_CRIGM2017-9343896.006.jpg
case_images: fig6
case_images: Type Homeobox 2 (CDX2) positive (Figure 6), GATA3 negative in neoplastic cells (Figure 7), and Uroplakin negative in neoplastic cells (Figure 8).
case_images: Bladder tumor with negative stain for GATA 3 in neoplastic cells.
case_images: CRIGM2017-9343896.007.jpg
case_images: PMC5469985_01_CRIGM2017-9343896.007.jpg
case_images: fig7
case_images: Type Homeobox 2 (CDX2) positive (Figure 6), GATA3 negative in neoplastic cells (Figure 7), and Uroplakin negative in neoplastic cells (Figure 8).
case_images: Bladder tumor with negative stain for Uroplakin in neoplastic cells.
case_images: CRIGM2017-9343896.008.jpg
case_images: PMC5469985_01_CRIGM2017-9343896.008.jpg
case_images: fig8
case_images: Type Homeobox 2 (CDX2) positive (Figure 6), GATA3 negative in neoplastic cells (Figure 7), and Uroplakin negative in neoplastic cells (Figure 8).